EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Activity
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

85 hedge funds and large institutions have $124M invested in Eiger BioPharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 31 increasing their positions, 19 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
85
Holders Change
-7
Holders Change %
-7.61%
% of All Funds
1.31%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
15
Increased
31
Reduced
19
Closed
20
Calls
$301K
Puts
$267K
Net Calls
+$34K
Net Calls Change
-$428K

Top Buyers

1
Ameriprise
1
Ameriprise
Minnesota
$36.6M
2
Morgan Stanley
2
Morgan Stanley
New York
$2.18M
3
Assenagon Asset Management
3
Assenagon Asset Management
Luxembourg
$1.16M
4
Russell Investments Group
4
Russell Investments Group
United Kingdom
$1.66M
5
6CM
5
683 Capital Management
New York
$17.1M

Top Sellers

1
VC
1
Vivo Capital
California
$22K
2
SCM
2
Soleus Capital Management
Connecticut
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
DC
4
Davenport & Co
Virginia
$1.23M
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$174K
Name Holding Trade Value Shares
Change 		Shares
Change %
PK
101
Pflug Koory
Nebraska
– -$7K -34 Closed
ACA
102
Atlas Capital Advisors
Wyoming
– -$6.68K -33 Closed
PCM
103
Penserra Capital Management
California
– -$5K -26 Closed
1 2 3 4
5